These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6103359)

  • 1. Beta-adrenergic blockade in congestive cardiomyopathy.
    Wetzel RC
    Lancet; 1980 May; 1(8176):1031. PubMed ID: 6103359
    [No Abstract]   [Full Text] [Related]  

  • 2. beta-Blockade and congestive cardiomyopathy.
    Lancet; 1981 Mar; 1(8220 Pt 1):598-9. PubMed ID: 6110828
    [No Abstract]   [Full Text] [Related]  

  • 3. Should beta adrenergic blocking drugs be used in congestive cardiomyopathy?
    Reddy KS; Bhatia ML
    Indian J Chest Dis Allied Sci; 1983; 25():49-53. PubMed ID: 6137453
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta blockade in congestive cardiomyopathy.
    Waagstein F; Hjalmarson A; Swedberg K; Wallentin I
    Lancet; 1981 Nov; 2(8255):1115-6. PubMed ID: 6118566
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.
    Swedberg K; Hjalmarson A; Waagstein F; Wallentin I
    Lancet; 1979 Jun; 1(8131):1374-6. PubMed ID: 87834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioselective beta blockade in hypertrophic cardiomyopathy.
    Webb-Peplos MM; Croxson RS; Khanna P; Raphael MJ; Steiner RE; Oakley CM; Goodwin JF
    Acta Cardiol; 1972; ():Suppl 15:263-7. PubMed ID: 4147610
    [No Abstract]   [Full Text] [Related]  

  • 7. [The hemodynamic effects of nifedipine in congestive cardiomyopathy (author's transl)].
    Schiavoni G; Mazzari M; Scabbia E; Coppola E; Domenichelli B; Manzoli U
    G Ital Cardiol; 1980; 10(2):161-6. PubMed ID: 7372031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.
    Swedberg K; Hjalmarson A; Waagstein F; Wallentin I
    Br Heart J; 1980 Aug; 44(2):117-33. PubMed ID: 6107090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology and current therapy of congestive heart failure due to idiopathic cardiomyopathy].
    Kambayashi M; Kumada T
    Nihon Rinsho; 1993 May; 51(5):1328-32. PubMed ID: 8101239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.
    Swedberg K; Hjalmarson A; Waagstein F; Wallentin I
    Br Heart J; 1980 Aug; 44(2):134-42. PubMed ID: 6107091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic blockade in the treatment of left-sided hypertrophic obstructive cardiomyopathy (HOCM).
    Rookmaker WA; Nieveen J; Kruizinga K; Blickman JR
    Acta Med Scand; 1971 May; 189(5):427-31. PubMed ID: 4397077
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of growth hormone replacement in a growth hormone deficient patient with underlying cardiomyopathy and severe congestive heart failure.
    Meyers DE; Maddicks-Law J; Seaton DM; Galbraith AJ; Cuneo RC
    J Heart Lung Transplant; 2005 Jan; 24(1):110-4. PubMed ID: 15653391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-adrenergic blockers in congestive heart failure: pro et contra?].
    Trifunović SL; Pavlović K
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():44-50. PubMed ID: 18193810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic blocking agents in congestive heart failure.
    Goldstein S
    Henry Ford Hosp Med J; 1986; 34(3):184-7. PubMed ID: 2879814
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta blockers in heart failure?].
    Modersohn D; Walde T
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):397-401. PubMed ID: 1352079
    [No Abstract]   [Full Text] [Related]  

  • 17. Should manipulation of myocardial substrate utilization patterns be a component of the congestive heart failure therapeutic paradigm?
    From AH
    J Card Fail; 1998 Jun; 4(2):127-9. PubMed ID: 9730106
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetic cardiomyopathy].
    Terashima M; Goto Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():347-53. PubMed ID: 12430252
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICI 50172) in coronary insufficiency. Preliminary results].
    Rousseau M; Vandenput F; Brasseur L
    Acta Cardiol; 1972; ():Suppl 15:239-54. PubMed ID: 4404471
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICI 50172) in coronary insufficiency. Preliminary results].
    Rosseau M; Vandenput F; Brasseur L
    Acta Cardiol; 1972; ():Suppl 15: 239-. PubMed ID: 4147615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.